Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death

被引:51
作者
Chen, GG [1 ]
Sin, FLF
Leung, BCS
Ng, HK
Poon, WS
机构
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Shatin, Hong Kong, Peoples R China
关键词
D O I
10.1002/jcp.20230
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
DNA-dependent protein kinase (DNA-PK), a nuclear serine/threonine kinase, is responsible for the DNA double-strand break repair. Cells lacking or with dysfunctional DNA-PK are often associated with mis-repair, chromosome aberrations, and complex exchanges, all of which are known to contribute to the development of human cancers including glioblastoma. Two human glioblastoma cell lines were used in the experiment, M059J cells lacking the catalytic Subunit of DNA-PK, and their isogenic but DNA-PK proficient counterpart, M059K. We found that M059K cells were much more sensitive to staurosporine (STS) treatment than M059J cells, as demonstrated by MTT assay, TUNEL detection, and annexin-V and propidium iodide (PI) staining. A possible mechanism responsible for the different sensitivity in these two cell lines was explored by the examination of Bcl-2, Bax, Bak, and Fas. The cell death Stimulus increased anti-apoptotic Bcl-2 and decreased pro-apoptotic Bcl-2 members (Bak and Bax) and Fas in glioblastoma cells deficient in DNA-PK. Activation of DNA-PK is known to promote cell death of human tumor cells via modulation of p53, which can clown-regulate the anti-apoptotic Bcl-2 member proteins, induce pro-apoptotic Bcl-2 family members and promote a Bax-Bak interaction. Our experiment also demonstrated that the mode of glioblastoma cell death induced by STS consisted of both apoptosis and necrosis and the percentage of cell death in both modes was similar in glioblastoma cell lines either lacking DNA-PK or containing intact DNA-PK. Taken together, our findings Suggest that DNA-PK has a positive role in the regulation of apoptosis in human glioblastomas. The aberrant expression of Bcl-2 family members and Fas was, at least in part, responsible for decreased sensitivity of DNA-PK deficient glioblastoma cells to cell death stimuli. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 52 条
[1]
Achanta G, 2001, CANCER RES, V61, P8723
[2]
ISOLATION OF 2 CELL-LINES FROM A HUMAN-MALIGNANT GLIOMA SPECIMEN DIFFERING IN SENSITIVITY TO RADIATION AND CHEMOTHERAPEUTIC DRUGS [J].
ALLALUNISTURNER, MJ ;
BARRON, GM ;
DAY, RS ;
DOBLER, KD ;
MIRZAYANS, R .
RADIATION RESEARCH, 1993, 134 (03) :349-354
[3]
γ-radiation sensitivity and risk of glioma [J].
Bondy, ML ;
Wang, LE ;
El-Zein, R ;
de Andrade, M ;
Selvan, MS ;
Bruner, JM ;
Levin, VA ;
Yung, WKA ;
Adatto, P ;
Wei, QY .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (20) :1553-1557
[4]
Burton EC, 2002, CANCER RES, V62, P6205
[5]
Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells [J].
Chakravarthy, BR ;
Walker, T ;
Rasquinha, I ;
Hill, IE ;
MacManus, JP .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :933-942
[6]
Role of DNA-dependent protein kinase in neuronal survival [J].
Chechlacz, M ;
Vemuri, MC ;
Naegele, JR .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (01) :141-154
[7]
Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways [J].
Chen, GG ;
Chak, ECW ;
Chun, YS ;
Lam, IKY ;
Sin, FL ;
Leung, BCS ;
Ng, HK ;
Poon, WS .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2003, 141 (03) :190-199
[8]
Excision repair cross-complementing rodent repair deficiency gene 2 expression and chloroethylnitrosourea resistance in human glioma cell lines [J].
Chen, ZP ;
McQuillan, A ;
Mohr, G ;
Panasci, LC .
NEUROSURGERY, 1998, 42 (05) :1112-1119
[9]
Functional interaction between DNA-PKcs and telomerase in telomere length maintenance [J].
Espejel, S ;
Franco, S ;
Sgura, A ;
Gae, D ;
Bailey, SM ;
Taccioli, GE ;
Blasco, MA .
EMBO JOURNAL, 2002, 21 (22) :6275-6287
[10]
Falchetti ML, 2000, INT J CANCER, V88, P895, DOI 10.1002/1097-0215(20001215)88:6<895::AID-IJC9>3.0.CO